“It’s like crossing Google with LinkedIn,” says
@MarkLogic
’s Imran Chaudhri about the company’s Pharma Research Hub, a data integration tool for clinical trials.
#DIA2019
#ClinicalTrials
That’s a wrap for our
#DIA2019
coverage! Thanks to everyone who took the time to come and chat with us over the past couple of days. Be sure to follow our Twitter to view the full length videos and articles as we release them. Until next time ✌️
Scientists at
@wyssinstitute
have developed a technique to deliver
#chemotherapy
to the lungs using red blood cells. The method involves binding chemotherapy-loaded nanoparticles to red blood cells, which are then injected into the
#bloodstream
.
#cancer
The world’s first Ebola vaccine has been approved for marketing by the European Commission. This is a monumental achievement for
@Merck
,
@WHO
,
@EU_Commission
, and sends a strong message of hope to everyone affected. Read more at
@thecantang
#Ebola
#vaccine
Catch this live webinar with expert speaker,
@TheIDApprentice
This webinar will address the use of
#molecular
rapid diagnostic tests for
#bloodculture
identification & the role of antimicrobial stewardship.
deCODE Genetics Unveils the Most High-Resolution Map of the
#HumanGenome
Two decades worth of work have cumulated into the first full-resolution map of the human genome, giving scientists info about how genes are passed down multiple generations and more.
@Immunovia
, Inc.’s blood test for
#pancreatic
#cancer
is being touted as the world’s first test for early detection of the disease, and has won approval in Massachusetts. Read more about the test by
@AyeshaR1202
.
Researchers at
@CRI_UTSW
have uncovered why certain melanoma cells are more likely to spread through the body, which could be used to help reduce the proportion of patients who progress from stage 3 melanoma to more-deadly stage 4 cancer.
#cancer
#melanoma
“There’s a lot of competition in the arena, which breeds success that’s upcoming for the clinical trial world, especially electronically,” says Janine Jones, Clinical Solutions Specialist for
@bioclinica
, when asked about the future of clinical trials
#DIA2019
Exploring Changes of Myeloid Cells with Chromogenic Multiplex IHC in Advanced
#LiverCancer
How is the
#tumor
microenvironment with multiplex
#immunohistochemistry
crucial for deciphering drug mechanisms of action on immune cells? Learn more:
@HalioDx
Bioinformatics is an important and in-demand job due to the wealth of big data in science. Check out this blog to learn how to market yourself better for a career in bioinformatics. Read more by
@miranabulsi123
.
#Bioinformatics
#Careers
#BigData
As
@DIA2019
approaches, Xtalks journalist
@thecantang
spoke with Daniel Piekarz, Head of Healthcare & Life Sciences at DataArt to learn more about how to simplify big data with customized solutions.
@DrugInfoAssn
When it comes to rare disease clinical trials, a family-centric approach is a priority for
@Synteract
. “We are getting everybody to sit down together and come up with a care plan that works with our clinical trials,” says Lisa Dilworth, VP, Rare & Orphan Diseases for the company.
We spoke with Sarah Ikard from
@ICONplc
about how patient data can be tracked outside the clinic, thanks to wearable technology. The full interview coming soon on
#DIA2019
#TheFutureOfClinicalTrials
Helllllllooooo San Diego!
The
@Xtalks
team has landed and are looking forward to an exciting couple of days covering
#DIA2019
this Monday & Tuesday. Stay tuned for content coming your way!
#SanDiego
A vaccine being developed by Swedish company
@Diamyd
has shown favorable safety and efficacy in a predefined genetic subset of type 1 diabetic patients. Read more about the trial & the promising results at by
@AyeshaR1202
#vaccine
#diabetes
#type1diabetes
Thanks to everyone who has taken a selfie sporting our Xtalks pins at
#DIA2019
! Don’t forget to post your pic with the hashtag
#XtalksRewards
and register on to claim your $10 Starbucks gift card. If you still need a pin just let us know in the replies 👇
“You’re seeing so much excitement around gene editing technology, around allogenic CAR T and other advanced biological ideas. You're also seeing, on the technology side, huge advances,” says
@DrugInfoAssn
’s Sudip Parikh about the most exciting trends in pharma.
#DIA2019
Xtalks had a discussion with
@BONESUPPORT_AB
CEO Emil Billbäck about Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market. You can read the interview with Emil Billbäck at by
@VeraKovacevic3
.
If you're at
#DIA2019
today or tomorrow, keep an eye out for Xtalks journalists
@TeganVersolatto
@thecantang
. They'll be handing out Xtalks pins that will land you a $10 Starbucks gift card if you tag
#XtalksRewards
on social w/ a selfie & register on
“What we’re seeing is the industry is much more amenable now to looking at
#data
in different ways to enable different decisions to be made in a timely manner.” - Patrick Hughes, Chief Commercial Officer,
@CluePoints
Xtalks had a discussion with Devon Adams, Senior Analyst for Policy & Legislative Support at
@ACSCAN
, about improving patient access to
#clinicaltrials
, decentralized approaches for
#oncology
trials & more. Read the full interview by
@VeraKovacevic3
here.
The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of
#cancer
researchers even before the first human genome was decoded in 2003.
#Bioinformatics
#HumanGenome
This webinar, brings together
#antimicrobial
resistance (AMR) experts to discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for
#antibacterial
drugs. Sign up now!
#ClinicalDevelopment
This webinar will present findings on the evolution of acute myeloid leukemia (AML) in response to FLT3i and
#chemotherapy
treatment, in which multiple clones had distinct mechanisms of drug resistance. Sign up now!
#AcuteMyeloidLeukemia
@MissionBio
Researchers at UT Southwestern Medical Center have stopped the progression of Duchenne muscular dystrophy in dogs using the
#CRISPR
#geneediting
technique. This is the first time this technique has been successfully used in a large mammal.
Research into alternative stem cell sources has identified urine derived renal progenitor cells (UdRPCs) as a possible option for use in regenerative kidney therapies in the future.
#stemcell
#kidney
#urine
Did you know
#MolecularGuidanceSystems
, or MGSs, can be rapidly identified for virtually any
#celltype
? Sign up for this webinar by
@SRI_Intl
to hear how MGS’s can deliver a wide variety of cargoes, ranging from small molecules to full length
#antibodies
.
Bioinformaticians use a combination of mathematics, computer science and biology to help
#scientists
make sense of the data gathered from research projects. Read on to learn about job titles within
#bioinformatics
!
Join this webinar by
@Oncodesign_SA
to learn about how the DRIVE-MRT solution enables the rationalization, design and optimization of targeted and effective
#radiopharmaceuticals
against specific
#cancers
.
Sanofi is accelerating nascent efforts in gene therapy, aiming to use its expertise in vaccines to catch up in a competitive field that's well ahead of the French pharma.
#pharma
#genetherapy
#raredisease
Decentralized clinical trials (DCT) are changing the way we work in
#clinicalresearch
, from participant recruitment &
#telehealth
visits to streamlined data collection. Learn more by
@THREADresearch
on methods to measuring decentralized study components.
Smart Manufacturing Meets the Bioreactor: Driving More Value and Consistency from Bioprocessing
How are
#bioreactor
analytics compatible with continuous manufacturing as a seamless path for future
#Pharma
4.0 initiatives?
#QualityControl
@aizon_ai_
🌟💬 Xtalks Spotlight: To gain insights into the top
#oncology
clinical trial trends shared at ESMO, we spoke with two experts from
@Fortrea
, Dr. Laura Vidal and Dr. Ken Morrison. ⏩ Watch + read the full Spotlight feature here:
#Cancer
#ESMO23
A 75-year-old California man has, after ten years of observation, been declared free of
#cancer
after an immune cell treatment wiped out his
#bloodcancer
and a decade passed without it returning.
This presentation by
@SyngeneIntl
will give the audience a good understanding of key questions to enable decision for way-forward,
#riskanalysis
and
#mitigation
strategies, parameter selection and evaluation for technology transfer.
Faster to produce than conventional
#vaccines
, the potential applications of synthetic
#mRNA
to prevent illness and treat diseases seems nearly limitless. Read more here.
#ICYMI
, Biogen announced their intention to restart
#clinicalstudies
of aducanumab. If approved, it would be the first disease-modifying
#drug
to treat
#Alzheimer
’s disease, plus the first to show that removing amyloid beta would lead to better outcomes.
Join this webinar to learn about how
@SyngeneIntl
performed an overall assessment and defined the phase-appropriate quality systems covering
#preclinical
research to
#clinical
-phase studies.
The effects of
#walnut
consumption in over 8,000 people has been studied by Harvard researchers over the past 20 years. They found that the nut reduces the risk of
#cardiovascular
diseases and increases life expectancy. Read more by
@miranabulsi123
here.
FDA approves first anti-malaria drug in over 18 years. An initial dose is taken before travel and is then intended to be taken once a week in high threat areas. Read more at
@miranabulsi123
#pharma
#malaria
#mosquito
Scientists have made a major advance in the pursuit of a safe and effective treatment for type 1
#diabetes
. Using
#stemcell
technology, researchers generated the first human
#insulin
-producing pancreatic cell clusters able to evade the immune system.
Using
#CRISPR
-Cas Screens to Reveal Fitness Genes and to Map Genetic Interactions
#Genomic
analyses are yielding a host of new information on the multiple genetic abnormalities associated with specific types of cancer.
@Michael_Aregger
@Lawson6Keith
In this Xtalks Spotlight discussion, Xtalks spoke with Rachel Colite, Vice President of Decentralized Clinical Trials at
@Cogstate
, who shared trends, considerations and benefits of remote and decentralized clinical trial implementation.
#ClinicalTrials
🔍💡 We spoke with Rick Hawkins, CEO and Chairman of
@Lumos_Pharma
, to learn about the company’s patient-centric strategy for pediatric rare disease drug development and more. Read the full interview with Hawkins at by
@VeraKovacevic3
#RareDisease
#PGHD
How to Navigate the Health Canada XML PM Requirements
As we enter 2021, the
@GovCanHealth
mandates and timelines become more important than ever. Register now to learn about the
#submission
requirements for
#drugproduct
information by
@ReedTechLifeSci
.
Researchers have harnessed CRISPR to target gene messages (messenger RNA) involved in early vertebrate development. This allows researchers to study genes that might previously have been difficult or impossible to manipulate.
#genetics
#CRISPR
#geneediting
Artificial Intelligence in Digital Pathology
Image analysis is an essential part of digital pathology. Do you know which artificial intelligence method will work best with your image data? Sign up to learn!
#DigitalPathology
#Imaging
#AI
@Visiopharm
Expanding Cancer Immunotherapy by Exploiting Recall Immunity – A New Co-Therapy Option for Checkpoint Inhibitors
Tomorrow's webinar will discuss expanding the
#patientpopulation
for checkpoint
#inhibitor
therapy. Sign up now!
@SRI_Intl
#Immunotherapy
Management of Gram-positive Bloodstream Infections: Collaboration Perspectives from the Laboratory and Antimicrobial Stewardship
What are the roles of a
#clinical
#microbiology
laboratory and
#antimicrobial
stewardship team?
@GenMark_Dx
@WHO
announced the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.
#Insulin
#diabetes
#healthcare
#DidYouKnow
, medical genetics company Invitae announced the launch of a mobile app that leverages Apple Watch data to better understand the genes that cause cardiovascular disease.
#medtech
#cardiology
#heartdisease
Eli Lilly is investing $400 million in its Indianapolis production site so it can make more diabetes treatments and prepare for pipeline products, resulting in 100 new jobs.
#pharma
#diabetestreatment
#pharmajobs
✅
@Merck
’s Winrevair received FDA approval as the first-in-class treatment for pulmonary arterial hypertension (PAH). Read about the biologic, which Merck acquired in its $11.5 acquisition of Acceleron, & its approval:
#RareDisease
#PulmonaryHypertension
🌟 In the latest
#XtalksSpotlight
, Cindy Markham, Chief Commercial Officer at
@thecentrallab
, shares insights on current challenges in
#clinicaltrials
and discusses strategies to overcome these obstacles. ⏩ Watch and read the discussion here:
Preventative genomics company
@phosphorus
has developed a comprehensive, preventative
#genetic
test that not only screens for
#disease
risk, but also provides information on
#health
and wellness indicators. Read more about the test by
@AyeshaR1202
.
CAR T
#CellTherapy
and Other Technologies Emerging in
#OncologyResearch
CAR T cell therapy, or adoptive cell therapy, is a type of treatment in which a patient’s own T cells are manipulated in a lab by adding an artificial receptor, or a “CAR.”
A Comparison of FDA, EMA & PMDA Regulatory Guidance for In Vitro Drug-Drug Interaction (DDI) Assessments
Discover the basic in vitro tests (CYP and transporter models) required today for regulatory compliance in DDI testing.
@Covance
#pharma
#drugsafety